Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy

 Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy

Recent in-vivo studies conducted in partnership with the University of Toronto confirm Formulation Candidates anti-seizure properties allowing for formalization of the patent application
TORONTO, Oc…